I agree
I thought that the bulk of the short unwinding activities would have happened last week, but Shortman is showing that there has been an increased of short positions - go figure
But, as a LTSH, I now have no fear of these professional shorters.
In fact, there's 37m shares to be purchased at a future date
Shorters used to win against Mesoblast, as there was always an exit pathway, mainly via CR.
But, the game has shifted.
Mesoblast got access to plenty of cash/ funds; and are likely to get more in terms of partnership $$$
Also, the convincing ODAC approval recommendation of 9-1 has put to bed about Mesoblast not have achieved anything.
In a space of a few months, Mesoblast will be achieving plenty.
So, I'm mildly curious as to why they professional shorters have increased their position on MSB, whereby now their is a higher risk to them - there's plenty of other ASX stock for them to focus on - go figure
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-1196
-
- There are more pages in this discussion • 11,875 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
3 | 75486 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online